Shengtai Bian

Dr. Shengtai Bian

Beijing Sport University
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2020 in Biosensors
Verified
Journal Article
Open access
PDF file
Shun YeShun Ye
Shun Ye
Shilun FengShilun Feng
Shilun Feng
LHLiang Huang
Liang Huang
Shengtai BianShengtai Bian
Shengtai Bian
Recent advances in lab-on-a-chip technology establish solid foundations for wearable biosensors. These newly emerging wearable biosensors are capable of non-invasive, continuous monitoring by miniaturization of electronics and integration with microfluidics. The advent of flexible electronics, biochemical sensors, soft microfluidics, and pain-free microneedles have created new generations of wearable biosensors that explore brand-new avenues to interface with the human epidermis for monitoring physiological status. However, these devices are relatively underexplored for sports monitoring and analytics, which may be largely facilitated by the recent emergence of wearable biosensors characterized by real-time, non-invasive, and non-irritating sensing capacities. Here, we present a systematic review of wearable biosensing technologies with a focus on materials and fabrication strategies, sampling modalities, sensing modalities, as well as key analytes and wearable biosensing platforms for healthcare and sports monitoring with an emphasis on sweat and interstitial fluid biosensing. This review concludes with a summary of unresolved challenges and opportunities for future researchers interested in these technologies. With an in-depth understanding of the state-of-the-art wearable biosensing technologies, wearable biosensors for sports analytics would have a significant impact on the rapidly growing field—microfluidics for biosensing.

19 January 2023 in Biosensors
Verified
Journal Article
Open access
PDF file
DLDong Liu
Dong Liu
ZLZhenyu Liu
Zhenyu Liu
Shilun FengShilun Feng
Shilun Feng
ZGZehang Gao
Zehang Gao
RCRan Chen
Ran Chen
Shengtai BianShengtai Bian
Shengtai Bian
Traditional exercise training monitoring is based on invasive blood testing methods. As sweat can reveal abundant blood-related physiological information about health, wearable sweat sensors have received significant research attention and become increasingly popular in the field of exercise training monitoring. However, most of these sensors are used to measure physical indicators such as heart rate, blood pressure, respiration, etc., demanding a versatile sensor that can detect relevant biochemical indicators in body fluids. In this work, we proposed a wearable microfluidic sweat chip combined with smartphone image processing to realize non-invasive in situ analysis of epidermal sweat for sports practitioners. The polydimethylsiloxane (PDMS) based chip was modified with nonionic surfactants to ensure good hydrophilicity for the automatic collection of sweat. Besides, a simple, reliable, and low-cost paper-based sensor was prepared for high-performance sensing of glucose concentration and pH in sweat. Under optimized conditions, this proposed chip can detect glucose with low concentrations from 0.05 mM to 0.40 mM, with a pH range of 4.0 to 6.5 for human sweat. The ability of this microfluidic chip for human sweat analysis was demonstrated by dynamically tracking the changes in glucose concentration and pH in long-distance running subjects.

23 September 2016 in Scientific Reports
Verified
Journal Article
Open access
SSShan She
Shan She
Shengtai BianShengtai Bian
Shengtai Bian
RHRuichao Huo
Ruichao Huo
KCKun Chen
Kun Chen
ZHZehuan Huang
Zehuan Huang
YWYongge Wei
Yongge Wei
High efficacy and low toxicity are critical for cancer treatment. Polyoxometalates (POMs) have been reported as potential candidates for cancer therapy. On accounts of the slow clearance of POMs, leading to long-term toxicity, the clinical application of POMs in cancer treatment is restricted. To address this problem, a degradable organoimido derivative of hexamolybdate is developed by modifying it with a cleavable organic group, leading to its degradation. Of note, this derivative exhibits favourable pharmacodynamics towards human malignant glioma cell (U251), the ability to penetrate across blood brain barrier and low toxicity towards rat pheochromocytoma cell (PC12). This line of research develops an effective POM-based agent for glioblastoma inhibition and will pave a new way to construct degradable anticancer agents for clinical cancer therapy.

24 October 2014 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
SSShan She
Shan She
Shengtai BianShengtai Bian
Shengtai Bian
JHJian Hao
Jian Hao
Jiangwei ZhangJiangwei Zhang
Jiangwei Zhang
JZJin Zhang
Jin Zhang
YWYongge Wei
Yongge Wei

1 January 2017 in Biomicrofluidics
Verified
Journal Article
Closed access
PDF file
LHLiang Huang
Liang Huang
Shengtai BianShengtai Bian
Shengtai Bian
YCYinuo Cheng
Yinuo Cheng
GSGuanya Shi
Guanya Shi
PLPeng Liu
Peng Liu
WWWenhui PE3012041 Wang
Wenhui PE3012041 Wang
Single cell analysis has received increasing attention recently in both academia and clinics, and there is an urgent need for effective upstream cell sample preparation. Two extremely challenging tasks in cell sample preparation—high-efficiency cell enrichment and precise single cell capture—have now entered into an era full of exciting technological advances, which are mostly enabled by microfluidics. In this review, we summarize the category of technologies that provide new solutions and creative insights into the two tasks of cell manipulation, with a focus on the latest development in the recent five years by highlighting the representative works. By doing so, we aim both to outline the framework and to showcase example applications of each task. In most cases for cell enrichment, we take circulating tumor cells (CTCs) as the target cells because of their research and clinical importance in cancer. For single cell capture, we review related technologies for many kinds of target cells because the technologies are supposed to be more universal to all cells rather than CTCs. Most of the mentioned technologies can be used for both cell enrichment and precise single cell capture. Each technology has its own advantages and specific challenges, which provide opportunities for researchers in their own area. Overall, these technologies have shown great promise and now evolve into real clinical applications.

14 April 2016 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
PZPengfei Zhang
Pengfei Zhang
JZJianxiong Zhang
Jianxiong Zhang
Shengtai BianShengtai Bian
Shengtai Bian
ZCZhongyao Chen
Zhongyao Chen
YHYawei Hu
Yawei Hu
PLPeng Liu
Peng Liu
A superhydrophobic microwell array chip (SMARchip) was developed for high-throughput screening.